Literature DB >> 20674406

Predisposition of allergy in patients with benign migratory glossitis.

Mustafa Goregen1, Mehmet Melikoglu, Ozkan Miloglu, Teoman Erdem.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the presence of allergy in patients with benign migratory glossitis (BMG) using patch and prick tests. PATIENTS AND METHODS: Eighty patients (40 BMG and 40 healthy controls) received patch and prick tests. If at least one test result was positive, patients were considered to be allergic.
RESULTS: The prick test was positive in 10 patients (25.0%) of the study group and in 4 patients (10.0%) of the control group. The patch test was positive in 12 patients (30.0%) of the study group and in 6 patients (15.0%) of the control group. When results of both tests were evaluated together, the study group showed a positive rate of 47.5% (n = 19), whereas the control group showed a positive rate of 22.5% (n = 9) (P = .02).
CONCLUSION: Our results revealed that a combination of prick and patch tests can significantly enhance the diagnostic accuracy of predisposition of allergy in patients with BMG.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674406     DOI: 10.1016/j.tripleo.2010.04.036

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  3 in total

Review 1.  Oral Mucosa as a Potential Site for Diagnosis and Treatment of Allergic and Autoimmune Diseases.

Authors:  Cristina Gomez-Casado; Javier Sanchez-Solares; Elena Izquierdo; Araceli Díaz-Perales; Domingo Barber; María M Escribese
Journal:  Foods       Date:  2021-04-28

Review 2.  Unmet diagnostic needs in contact oral mucosal allergies.

Authors:  Paola Lucia Minciullo; Giovanni Paolino; Maddalena Vacca; Sebastiano Gangemi; Eustachio Nettis
Journal:  Clin Mol Allergy       Date:  2016-09-01

3.  Geographic Tongue and Associated Risk Factors among Iranian Dental Patients.

Authors:  Marieh Honarmand; Leila Farhad Mollashahi; Masomeh Shirzaiy; Marziye Sehhatpour
Journal:  Iran J Public Health       Date:  2013-02-01       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.